Concepedia

Publication | Closed Access

Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for Cancer

150

Citations

38

References

2006

Year

Abstract

Based on preclinical validation studies, IMC-18F1 anti-VEGFR-1 has potential to provide clinical benefit to cancer patients.

References

YearCitations

Page 1